Raincy Montfermeil Hospital Group
10
2
2
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)
Role: lead
French National Observatory on Infective Endocarditis
Role: collaborator
Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children
Role: lead
S-ICD French Cohort Study (HONEST)
Role: collaborator
Study of the Impact of a Physical Activity Programme on the Quality of Life of Patients With Inflammatory Bowel Disease
Role: lead
"Effects of the Vaccin Against COVID 19 in a Cohort of Dialysis Patients: Adverse Events and Immunological Response"
Role: lead
Evaluation of the Impact of an Oral and Practical Presentation of Intrauterine Devices by a Health Professional on Women's Opinion as a Possible Contraceptive Method
Role: lead
Evaluation of a Locoregional Anesthesia Protocol by Pudendal Block in Reconstructive Surgery Clitoral
Role: lead
Complex Post-traumatic Stress Disorder: What Symptomatological Specificities
Role: lead
Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19
Role: lead
All 10 trials loaded